IL6 and endothelial dysfunction: Elevated inflammatory markers, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), have been observed in patients with PAD, contributing to endothelial dysfunction and plaque formation (37, 38).